Nippon Chemiphar Co. Ltd. | Ownership
Companies that own Nippon Chemiphar Co. Ltd.
Norges Bank Investment Management
80,699
1.89%
3,799
0%
12/31/2017
Fidelity Management & Research Co.
56,281
1.32%
2,296
0%
07/31/2018
The Vanguard Group, Inc.
51,752
1.21%
0
0%
07/31/2018
Nomura Asset Management Co., Ltd.
44,899
1.05%
699
0%
07/31/2018
Dimensional Fund Advisors LP
33,900
0.8%
600
0%
04/30/2018
Daiwa Asset Management Co. Ltd.
22,000
0.52%
2,300
0%
07/31/2018
Nikko Asset Management Co., Ltd.
20,898
0.49%
-402
0%
08/20/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
9,000
0.21%
0
0%
07/31/2018
Banque Cantonale Vaudoise (Investment Management)
7,500
0.18%
0
0.01%
03/31/2018
AXA Investment Managers Asia (Singapore) Ltd.
7,200
0.17%
2,700
0.02%
03/31/2018
| Address |
2-2-3 Iwamoto-cho
Tokyo Tokyo 101
Japan
|
|
Employees
|
- |
| Website |
http://www.chemiphar.co.jp |
| Updated |
07/08/2019 |
| Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments. |
